Bay Ali, Bosnak Vuslat, Leblebisatan Göksel, Yavuz Sibel, Yilmaz Fatih, Hizli Samil
Division of Pediatric Hematology, Department of Pediatrics, School of Medicine, Gaziantep University, Gaziantep, Turkey.
Pediatr Hematol Oncol. 2012 Apr;29(3):211-4. doi: 10.3109/08880018.2012.666783.
Hemophagocytic lymphohistiocytosis (HLH) is a rare clinical syndrome characterized by uncontrolled activation of cytotoxic T cells and antigen-presenting cells. Common clinical manifestations include high fever, maculopapular rash, neurological symptoms, coagulopathy, and abnormal liver function tests [1]. HLH can be either primary, that is, due to an underlying genetic defect, or secondary, associated with malignancies, autoimmune diseases, or infections. The true incidence of secondary HLH is difficult to define. Infection associated HLH are most commonly associated with viral infections mainly of the herpes group, with Epstein-Barr virus (EBV) that is proposed to be the most common cause [2]. Despite the high incidence of hepatitis A virus (HAV) infection in the pediatric population in general, there are few pediatric case reports in the literature about HAV-associated hemophagocytic syndrome [3]. We encountered 2 patients with HAV-associated hemophagocytic syndrome.
噬血细胞性淋巴组织细胞增生症(HLH)是一种罕见的临床综合征,其特征为细胞毒性T细胞和抗原呈递细胞的失控激活。常见临床表现包括高热、斑丘疹、神经症状、凝血病和肝功能检查异常[1]。HLH可以是原发性的,即由于潜在的遗传缺陷,也可以是继发性的,与恶性肿瘤、自身免疫性疾病或感染有关。继发性HLH的真实发病率难以确定。感染相关的HLH最常与主要为疱疹病毒组的病毒感染相关,其中EB病毒(EBV)被认为是最常见的病因[2]。尽管甲型肝炎病毒(HAV)感染在儿童总体人群中发病率很高,但文献中关于HAV相关噬血细胞综合征的儿科病例报告很少[3]。我们遇到了2例HAV相关噬血细胞综合征患者。